
| Salt Composition: | Nitroglycerin (6.4mg) |
| Manufacturer: | Bi-Cure Remedies |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Bioglyc 6.4 Tablet CR is used to treat and prevent heart-related chest pain (angina) by relaxing and widening blood vessels. Bioglyc 6.4 Tablet CR is a medication used to treat and prevent angina, a condition characterized by heart-related chest pain due to insufficient blood flow to the heart muscle. This medicine works by relaxing and widening blood vessels, allowing blood to flow more easily to the heart. It is important to take this medication as prescribed by your doctor, and it can be taken with or without food. Common side effects include headaches and dizziness, which may increase the risk of falls. It is crucial to avoid alcohol while taking this medication as it can exacerbate side effects. Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding before using this medicine.
Bioglyc 6.4 Tablet CR is a nitrate. It works by relaxing the blood vessels and increasing the supply of blood and oxygen to the heart while reducing its workload, thereby preventing/treating attacks of angina (chest pain).
Can I take sildenafil if I am taking Bioglyc 6.4 Tablet CR?
No, you should not take sildenafil if you are taking Bioglyc 6.4 Tablet CR. Taking these two medications together can cause an excessive drop in blood pressure, which may even be life-threatening.
What effect does Bioglyc 6.4 Tablet CR have on blood pressure?
Bioglyc 6.4 Tablet CR decreases blood pressure by relaxing the blood vessels. However, it is not recommended for treating high blood pressure and its use may cause a drop in blood pressure that can lead to lightheadedness, especially when changing your position suddenly.
Does the effect of Bioglyc 6.4 Tablet CR wear off after some time?
Yes, excessive use of Bioglyc 6.4 Tablet CR may cause tolerance which means that Bioglyc 6.4 Tablet CR may lose its effectiveness on you. Therefore, doctors usually prescribe the smallest dose required for effective relief of acute angina attack. This helps maintain the effectiveness of Bioglyc 6.4 Tablet CR.
What does too much Bioglyc 6.4 Tablet CR do?
Taking excessive Bioglyc 6.4 Tablet CR can result in low blood pressure, sweating, nausea, vomiting, headache, a weak and fast pulse. There may also be weakness, lightheadedness when standing, and the patient could even faint. In such cases, emergency medical treatment is necessary.
Can I stop using Bioglyc 6.4 Tablet CR as I feel better now?
Stopping Bioglyc 6.4 Tablet CR suddenly may cause angina attacks, especially if you have been using it for several weeks or more. Talk to your doctor who will advise you to gradually reduce the dose over 4 to 6 weeks before stopping completely.
Does Bioglyc 6.4 Tablet CR stop heart attacks?
Bioglyc 6.4 Tablet CR is prescribed to prevent angina (chest pain) attacks in patients with coronary artery disease. In this condition, the blood vessels supplying the heart become narrowed due to which the heart has to work harder to get enough oxygen. Bioglyc 6.4 Tablet CR prevents angina by relaxing the blood vessels so that the heart does not have to work very hard. Also, relaxation of the coronary arteries increases the oxygen supply to the heart.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Bioglyc 6.4 Tablet CR may be taken with or without food, but it is better to take it at a fixed time.
Alcohol
Consuming alcohol while taking Bioglyc 6.4 Tablet CR may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
Breastfeed
Bioglyc 6.4 Tablet CR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy
Bioglyc 6.4 Tablet CR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.